2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$11.86+$0.05 (+0.41%)
Price as of Nov 11, 2026 7:55 PM EST- $1.3BMarket Cap
- -0.42%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$11.86+$0.05 (+0.41%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.81 | ||
Change | -$0.72 (-5.75%) | ||
Open | $12.68 | ||
High | $12.95 | ||
Low | $11.56 | ||
Previous Close | $12.53 | ||
Volume | 1,928,600 | ||
30-Day Average Volume | 1,879,026 | ||
1-Week Change | -12.06% | ||
1-Month Change | -19.00% | ||
1-Year Change | -0.42% | ||
3-Year Change | 6.11% | ||
5-Year Change | -88.53% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $828.7M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $193.4M | ||
Net Income | -$10.4M | ||
Free Cash Flow | $15.7M | ||
EBIT | -$6.2M | ||
EBITDA | -$1.8M | ||
Net Working Capital | $402.9M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -807 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 4 | ||
P/E | -131 | ||
PEG | -4 | ||
Price/Free Cash Flow | 84 | ||
Price/Operating Cash Flow | 58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue